Table 2.
Characteristics | Number of cases (n) | Mean (Standart deviation) | Range |
---|---|---|---|
Age (Year) |
131 |
36 (12.42) |
18–68 |
Atopic |
96 |
31 (8.72) |
18–57 |
Non-atopic |
35 |
52 (6.57) |
42–68 |
Control |
75 |
43 (7.68) |
23–65 |
Female (Total) |
96 |
|
|
Atopic |
63 |
|
|
Non-atopic |
30 |
|
|
Control |
50 |
|
|
Male (Total) |
35 |
|
|
Atopic |
33 |
|
|
Non-atopic |
5 |
|
|
Control |
25 |
|
|
Duration of asthma (Year) |
131 |
4.52 (5.28) |
0–35 |
FEV1 (%) |
|
|
|
Asthma |
131 |
68.60 (12.67) |
37–97 |
Control |
75 |
95.70 (14.56) |
90–115 |
Total IgE (kU/I) |
|
|
|
Asthma |
131 |
175.77 (220.28) |
4–986 |
Control |
75 |
45.32 (30.25) |
5–89 |
Eosinophil (%) |
|
|
|
Asthma |
131 |
3.39 (2.9) |
0–14 |
Control |
75 |
1.10 (0.5) |
0–3 |
Skin prick test (Asthma) |
|
|
|
Positive |
96 |
|
|
Negative | 35 |
FEV1: Forced expiratory volume 1.